Duke from on High
            Pointed spires, vigilant gargoyles and gothic towers rise above the trees in the woods of Durham.
        
    Poliovirus Therapy for Recurrent Glioblastoma Has 3-Year Survival Rate of 21%
            A genetically modified poliovirus therapy developed at Duke Cancer Institute shows significantly improved long-term survival for patients with recurrent glioblastoma, with a three-year survival rat
        
    2018 State of the School Address
            Presented by Mary E. Klotman, MD, Dean, Duke University School of Medicine
Part 1
[video:https://youtu.be/uNVbTY1guNM]
        
    Neurology and Men's Health, Part 2: ALS
            The second entry in our “Neurology and Men’s Health” series focuses on amyotrophic lateral sclerosis, or ALS.
        
    Faculty Registration now open! Writing from the Reader’s Perspective
            Registration now open for SOM Faculty
Registration will open to all others on June 25
 
        
     
             
            